RaymondsIndex

Every Monday, the same uncomfortable truth resurfaces: by the time a company's distress is legible in its financial statements, the people who needed to act already missed their window. This week's radar makes the point in two languages. The domestic signal. Korea Exchange's review of 2025 fiscal-year filings flagged 42 KOSDAQ companies with delisting triggers — and all 42 traced back to the same root cause: a failed or qualified audit opinion. Twenty-three hit a trigger for the first time this year; eleven failed for a second consecutive year; eight, for a third, and are now suspended pending liquidation trades. More telling than the headline number is a quieter one: newly designated "investment caution" issues rose to 43, a jump of 12 over the prior year. One flagged firm, Samyoung E&C, is simultaneously fighting a management-control lawsuit — a reminder that delisting risk and governance conflict tend to travel together. The global parallel. ...

Korea just gave minority investors a new tool, and it's worth understanding exactly what it can and cannot do. Under an amended Commercial Act, the duty of loyalty owed by company directors has been rewritten. Where the law once required directors to act faithfully "for the company," Article 382-3 now requires them to act for "the company and its shareholders ," and to treat all shareholders fairly. The shareholder-loyalty principle took force in 2025; the broader package — independent-director requirements (one-third of the board for large listed firms), a strengthened 3% voting cap, and the separate election of audit-committee members — phases in through July and September 2026. Alongside it, Korea moved to mandate cancellation of treasury shares, closing a mechanism long used by controlling families to entrench control with little direct ownership. This is a real shift. For the first time, a board that engineers a merger or a dilutive capital raise purely f...

Two take-privates closed within months of each other on opposite sides of the Sea of Japan. They used the same instrument. They produced opposite outcomes for the people who didn't sit at the table. In Korea, a private equity fund took the waste-management company Koentech private in mid-2025 at ₩9,000 per share. The fund assembled control through a tender offer, on-market purchases, and finally a comprehensive share swap. The tender offer fell short of plan — it secured about 20.2% — so the last resisting minority block, roughly 12.9% of the company, was forced out through the swap at that same ₩9,000. An independent valuation had called the price fair. Six months later, with no meaningful change in the business or its end-market, the fund moved to sell the company outright for a price in the mid-₩700 billion range — close to ₩15,000 per share, nearly double. Reporting estimated the squeezed-out minorities' stake carried roughly ₩40 billion of additional value they never rece...

The raid came after the stock had already moved. On May 28, 2026, prosecutors from the Seoul Southern District Prosecutors' Office executed search and seizure warrants at NH Investment & Securities and DI Dongil — a Korean industrial company listed on the KOSPI. The investigation targets an alleged market manipulation scheme in which more than one trillion Korean won was coordinated across dozens of accounts using artificial cross-trades. Prosecutors allege that the manipulation group used a minority shareholder activism campaign as cover, pressuring company management to enter a share buyback trust agreement while quietly managing the stock price behind the scenes. Retail investors, watching the price respond to what appeared to be governance pressure, bought in. They were the designed exit. The same week, across the Pacific On May 6, 2026, the U.S. Securities and Exchange Commission — alongside the Department of Justice — charged 21 individuals with a sprawling insider tr...

Introduction: The Survival Trade In South Korea, KOSDAQ delistings tripled over two years: 8 companies were removed from the market in 2023, rising to 20 in 2024 and 38 in 2025, according to Korea Exchange data cited in the Seoul Economic Daily (May 10, 2026). Regulators responded by raising the minimum market capitalization threshold from ₩4 billion to ₩15 billion in January 2026, with another increase to ₩20 billion scheduled for July. The result? A wave of “defensive M&A.” Listed Korean small-cap companies are acquiring businesses with stable revenue — not to build strategic value, but to pass the listing threshold. Kespion (079190), a communications antenna firm, acquired MBTB, an acne patch specialist, for ₩2.1 billion in January. Kespion had recorded operating losses of ₩5.4 billion in 2024 and ₩2.7 billion in 2025. At the time of acquisition, MBTB itself was unprofitable. As of late May, Kespion’s market cap sits at approximately ₩22.1 billion — barely above the ₩20 billio...

On May 22, 2026, a KOSDAQ-listed company called Hankook Advanced Materials (062970) approved a KRW 10 billion private convertible bond. Half of that issuance went to Specialty Investment Co., an entity confirmed to be a special-related party of the de facto controlling shareholder, Satoshi Holdings. The disclosed use of proceeds was a single line: "acquisition of securities of other companies." That single line is the entire window the minority shareholder has into where KRW 10 billion of newly created liability is about to go. This is not a unique case. It is a template. The Cash Governance Question When a company raises capital, three things can happen. The cash goes into operations — equipment, hiring, inventory, working capital. The cash goes into capital efficiency — buybacks, dividends, debt reduction. Or the cash goes into something that looks like neither — short-term financial products, related-party loans, "other securities" with no further specifi...

Introduction In 2025, Herbalife Korea posted ₩2.8 billion in net income. By most standards, that looks like a profitable year. But the company simultaneously paid ₩8 billion in dividends to its US parent — a payout ratio of 283.7%. Over three years, retained earnings fell from ₩43.9 billion to ₩14.9 billion. More than 30% of revenue left the Korean subsidiary as service fees. When asked thirteen direct questions about the structure behind these numbers, the company said nothing. This is not a unique story. It is a pattern. The CEI Question The Capital Efficiency Index (CEI) in RaymondsIndex asks a deceptively simple question: Is the capital being deployed by this company actually generating returns — and returning them to shareholders? A low ROIC is one signal. But CEI is designed to catch something more specific: situations where capital is configured to move out of the company rather than compound within it. This includes subsidiaries that consistently pay out more than they ea...

1. The Week Opens With a Signal On May 19, 2026, Seoul Central District Prosecutors summoned a witness from the emergency response committee of Homeplus short-term bond victims. The investigation into MBK Partners — Korea's largest private equity fund operator — has entered its final stages. The allegation is stark: MBK management allegedly pushed ahead with issuing electronic short-term bonds while already anticipating Homeplus's financial crisis and a credit rating downgrade. The National Pension Service estimates its exposure at approximately ₩900 billion ($630 million). Retail investors who bought those bonds had no access to the same information. This is a Monday. And the week begins with a red zone signal. 2. What a Relational Risk Radar Actually Detects The Homeplus case is not an anomaly. It follows a structural pattern that repeats across Korean capital markets — and increasingly, across global private equity. At the center of RaymondsIndex's analytical frame...

In March 2026, Kakao — South Korea's dominant messaging and fintech platform — announced a deal that made headlines for all the right reasons: LY Corp, LINE Yahoo's investment vehicle, was injecting ₩300 billion into Kakao Games, becoming its new largest shareholder. The framing was classic: global ambitions, fresh capital, a Japanese tech giant entering Korean gaming. But the data told a different story. The Structure Underneath Kakao Games revenue had already collapsed — from ₩1.15 trillion in 2022 to ₩465 billion in 2025, a decline of nearly 60% in three years. Kakao, the parent, had simultaneously been pivoting toward AI, cutting its affiliate count from 147 to 94, shedding gaming subsidiaries like Nexports, Neptune, and Nimble Neuron. Kakao Games was not sold at its peak. It was sold on the descent — with Kakao retaining 14% and repositioning itself as an AI-focused platform while the subsidiary absorbed the legacy decline. The same week, a...

On May 6, 2026, South Korea's National Tax Service announced tax investigations into 31 listed companies — 8 on the KOSPI, 15 on the KOSDAQ — suspected of orchestrating stock manipulation, tunneling, and in some cases, deliberately forcing their own delistings. The suspected total illicit amount: over 2.2 trillion won (approximately $1.6 billion USD). One case in the investigation is particularly instructive. A controlling shareholder allegedly withheld audit documentation on purpose, engineering the company's own delisting. By the time individual investors realized what was happening, the damage was already irreversible. The controlling shareholder had already exited. What remained — the loss — was absorbed entirely by minority investors. The financial statement wasn't the signal. It was the aftermath. Information Asymmetry: The Operating System of Relational Risk This is information asymmetry in its most operationally precise form. The term — first formalized by George Ak...

Korea declared war on its corporate zombies. In February 2026, the Financial Services Commission and Korea Exchange jointly announced a "concentrated delisting management period" — running through June 2027 — with a dedicated task force of 20 regulators assigned to accelerate the removal of distressed firms. KRX's own simulation estimates that up to 220 KOSDAQ-listed companies could face delisting proceedings this year alone. Improvement windows have been cut from 18 months to 12. New triggers now include persistent penny-stock status and semi-annual checks for full capital impairment. It is the most aggressive market clean-up in KOSDAQ's modern history. Meanwhile, across the world, the UK's Resolution Foundation issued its own warning at the start of 2026: thousands of zombie businesses — kept artificially alive through years of low interest rates and pandemic-era support — are now buckling under what the Foundation called a "triple whammy" of high b...

 In March 2026, the Bank of Korea reported something that deserves more attention than it received. Korea's M2 money supply grew by ₩18.5 trillion in a single month — reaching a total of ₩4,132.1 trillion. The driving force? Nonfinancial corporations added ₩34.9 trillion to short-term deposits and money market instruments, classified in the data as funds "awaiting investment." That phrase — awaiting investment — is doing a lot of work. And for individual investors, it should raise an immediate question: when exactly does the waiting end? --- The CGI Signal: Raised Capital That Doesn't Move The Cash Governance Index (CGI) is one of four leading indicators in the RaymondsIndex framework. It measures the relationship between capital raised and capital deployed — specifically: how much of what a company raised is actually being used for business, versus being parked in financial instruments generating passive interest income. A high CGI score indicates that raised capital...

In May 2026, two stories unfolded on opposite sides of the globe — and they asked the same question. In South Korea, HLB Innovation, a KOSDAQ-listed biotech company, issued ₩40.5 billion in zero-coupon convertible bonds, with the stated purpose of funding its subsidiary's CAR-T therapy clinical development pipeline. In the United States, Meta disclosed a 7% increase in AI capital expenditure for 2026, contributing to $700+ billion in projected Big Tech AI infrastructure spending. Investors did not celebrate Meta's announcement. They demanded evidence of return on invested capital. Two different markets. Two different scales. One identical underlying question: when a company deploys capital, is that capital actually working? What CEI Measures The Capital Efficiency Index is one of four leading indicators in the RaymondsIndex framework. It measures the alignment between capital deployment and value generation, tracking ROIC, asset turnover ratios, and investment deviation. A decl...

This week, two stories from opposite sides of the world are pointing at the same structural problem: what happens when the people running companies make decisions that look like growth but function as preservation — of their own position, their own listing, their own seat at the table. The Korea Signal: When M&A Becomes a Survival Tool The Seoul Economic Daily reported this week that a wave of "defensive M&A" is sweeping Korea's KOSDAQ market. Listed small and mid-cap companies — facing dramatically tightened delisting thresholds set to take effect in July 2026 — are acquiring outside businesses not to create genuine value, but to hit the revenue and market cap numbers required to stay listed. The numbers are striking. One biotech firm acquired a pharmaceutical company and reported revenue growth of 135%. An education company acquired a tutoring brand and reported 248% revenue growth in one quarter. The acquisitions are real. The growth in the numbers is real. ...

Introduction Two news items this week, from opposite sides of the Pacific, tell the same story. In Korea, Enchem — a KOSDAQ-listed battery materials company — has accumulated over 275 billion KRW in outstanding convertible bonds. The auditor has flagged going-concern uncertainty. The largest shareholder's shares were subject to forced selling (반대매매). The company was designated as an unfaithful disclosure entity. And yet: none of this is visible in a single-quarter income statement. The signals were structural, relational, and financial governance-based — long before the results showed up on paper. In the United States, activist investor Impactive Capital filed a proxy challenge against WEX Inc., arguing that the company's combined CEO/Chair structure and capital-allocation practices have driven sustained underperformance in ROIC and total shareholder return. Again: the issue is not a single bad quarter. It's a governance structure that insulates the wrong incentives. ...

In baseball, a sacrifice bunt is a strategic play. The batter gives up an out — deliberately — so another runner can advance. The team scores. The batter's statistics suffer. It is not failure. It is design. In corporate finance, the same logic applies. Not every company in a multi-asset portfolio is meant to generate returns for all stakeholders. Some are positioned to absorb losses, serve as debt warehouses, or fund exits for the controlling investor — while minority shareholders and institutional creditors absorb the downside. This is the sacrifice play. And Korea's Homeplus case is one of the most instructive recent examples. The Homeplus Timeline In 2015, MBK Partners — Korea's largest private equity firm — acquired Homeplus for approximately 7.2 trillion won, the largest PE deal in Korean history. Over the following decade, store assets were sold off in a series of sale-and-leaseback transactions, reportedly generating around 4 trillion won in proceeds. By Mar...

On the morning of May 6, 2026, the U.S. Department of Justice and the Securities and Exchange Commission unveiled one of the most sweeping insider trading prosecutions in recent memory. Thirty individuals were criminally charged; 21 faced simultaneous civil enforcement by the SEC. At the center of the scheme: a Yale Law-trained mergers and acquisitions attorney who had worked at Sidley Austin, Latham & Watkins, and Goodwin Procter — three of the most prominent M&A practices in the world. From 2018 to 2024, he allegedly extracted material nonpublic information from nearly 30 pending corporate transactions. That information moved through a structured network — participants reportedly used code words like "Torahs" and "Mitzvahs" — whose members traded ahead of public announcements and split the profits. Individual investors, reading the same press releases hours or days later, absorbed the other side of those trades. The Architecture of Information Asymmetry ...

In December 2025, the Bank of Japan raised its policy rate from 0.50% to 0.75%. The number looks small. The implication is not. After three decades during which money cost nothing, an estimated 210,000 zombie companies in Japan are being repriced in real time. Corporate bankruptcies crossed 10,000 cases in 2025 , the highest in 12 years. A new law expected to take effect in 2026, the Early Business Revitalization Act, will allow majority-vote private restructuring — a deliberate signal that the state no longer wants every distressed firm kept alive. Korea is on the same curve, on a different timeline. The Korea Exchange has confirmed 42 KOSDAQ companies are at delisting risk this cycle , up 4 from a year ago. Eleven of them — including Samyoung E&C, Jeil M&S, COSNINE, TOBESOFT, EOFLOW and Korea United Pharm — have now received two consecutive years of auditor disclaimers. Eight more, after three years, are already past decision and in suspended liquidation. KRX has compress...

 In April and May 2026, Korean biotech companies collectively issued more than 1.1 trillion won — approximately $807 million — in zero-coupon convertible bonds. The structure is simple: no interest, no maturity coupon, just a bet on share-price upside embedded in the conversion option. D&D Pharmatec alone raised 226.5 billion won ($166 million) in a single deal, the largest CB transaction in the Korean biotech sector this year (Seoul Economic Daily, 2026.05.03). For issuing companies, the logic is compelling. Capital arrives with no cash-outflow burden. The balance sheet swells. Optically, the company looks well-funded. But the question that matters to individual investors is not how much was raised. It's where the money went. The CGI Signal RaymondsIndex tracks this question through the Cash Governance Index (CGI) — one of four leading indicators that measure the structural health of a company's relationship with its own capital. CGI specifically monitors three patterns: t...

Introduction: Fermi’s 48-Hour Double Exit On April 20, 2026, Fermi — the AI nuclear power infrastructure startup co-founded by former Texas Governor and former U.S. Secretary of Energy Rick Perry — announced that founding CEO Toby Neugebauer had stepped down. Forty-eight hours later, CFO Miles Everson filed an SEC disclosure noting his resignation without “good reason.” Shares fell 22% in a single session. Market capitalization collapsed from nearly $20 billion at its October 2025 peak to $3.4 billion. The financials hadn’t moved. The executive network had. The CEI Signal: What Leadership Changes Tell Us Before Earnings Do RaymondsIndex tracks corporate health through four leading indicators. CEI — the Corporate Executive Index — monitors who enters and exits a company’s decision-making circle, and crucially, in what sequence and under what circumstances. When a CEO departs, the event is visible. What is harder to see is whether that departure reflects a deliberate strategy by controll...

In the first week of May 2026, two stories landed on opposite sides of the Pacific — and they told the same story. In Seoul, The Korea Herald and The Investor reported that national security reviews are no longer a predictable procedural step in Korean cross-border M&A. They have become a strategic weapon. Lawmakers from both ruling and opposition parties are now pushing legislation that would extend security screening to minority stake acquisitions and indirect investments — not just controlling interests. The Korea Zinc vs. MBK battle in 2024 was the opening act: a domestic private equity firm with significant foreign investor exposure was subjected to national security arguments by the target company's management as a defense mechanism. In Boston, Roche announced on May 7 that it has entered into a definitive merger agreement to acquire PathAI — an AI-powered digital pathology company — for $750 million upfront, with milestone payments of up to $300 million additional, for a...

M&A의 가장 강력한 신호는 종종 가장 조용한 곳에서 온다. 2026년 5월 첫째 주, 두 건의 인수 소식이 동시에 업계의 시선을 끝었다. 하나는 서울에서, 하나는 런던에서. 두 딜의 공통점은 단 하나다 — 인수자가 그 누구도 예상하지 못했다는 것. 태광그룹: 침묵의 포식자 석유화학 대기업으로만 알려졌던 태광그룹이 조용히 한국 M&A 시장의 새 주역으로 부상했다. 아시아투데이(2026.05.07)의 보도에 따르면, 태광그룹의 자산 총액은 불과 1년 만에 8조7,000억원에서 11조5,600억원으로 약 33% 증가했다. 계열사 수는 20개에서 38개로 두 배 가까이 늘었고, 재계 순위는 59위에서 48위로 11계단 상승했다. 애경산업 인수 추진, 동성제약 투자, 코트야드 메리어트 호텔 인수 — 업종을 가리지 않는 포트폴리오 전환이다. 이 과정이 주목받는 이유는 속도가 아니라 방식이다. 태광그룹은 화려한 기자회견도, 공격적인 투자 선언도 없이 조용히 계열사를 늘려왔다. "은둔의 태광"이라는 별명이 무색하게 이미 행동은 끝나 있었다. Bullish: 전통 인프라를 산 암호화폐 거래소 영국에서도 비슷한 역설이 작동했다. 암호화폐 거래소 Bullish가 영국 기반 주식 이전 대리인(transfer agent) Equiniti를 $4.2B에 인수한다고 발표했다(Bloomberg, 2026.05.05). Equiniti는 약 3,000개 발행사와 2만개 기업 고객에게 서비스를 제공하고, 연간 $500B 규모의 결제를 처리하는 전통 자본시장의 핵심 인프라다. 이 딜의 역설은 명확하다. 암호화폐 거래소가 왜 150년 역사의 전통 증권 서비스사를 샰는가? Bullish의 답은 간단하다 — 토큰증권 시대의 병목은 블록체인 기술이 아니라 기존 자본시장 인프라다. Equiniti의 주주 명부 관리, 배당 처리, 기업 행동(corporate action) 시스템을 블록체인 위에 올리는 것이 목표다. 학술적 관점: 예상 밖 인수자의 통합 과제 이처럼 이종...

In the first week of May 2026, UniCredit formally opened its €35 billion all-share takeover offer for Commerzbank — the largest cross-border European banking acquisition attempted since the 2008 financial crisis. According to Bloomberg (2026.05.05), the offer price of €31.07 per Commerzbank share represented an 8.7% discount to the market price at the time of announcement. The German government, retaining a 12% stake in Commerzbank, publicly described the approach as hostile. Commerzbank's CEO called the valuation "too low" and released an updated standalone strategy framed explicitly as a rebuttal to the bid. Observers have framed the standoff as a pricing dispute. A closer reading suggests something more fundamental: the absence of a credible integration narrative on the acquirer's side. --- The Academic Diagnosis Research on post-merger integration has consistently identified planning readiness — not valuation — as the primary determinant of deal success. Haspeslag...